Investor Presentaiton
CT LVASTM product release in Australia
4DMedical™
•
CT LVASTM provides an similar report to XV LVASⓇ but utilises widely available CT imaging infrastructure (instead of X-ray).
•
Provides clinicians and patients with the benefits of XV Technology®, significantly growing the accessibility of functional lung imaging for
Australians living with lung disease.
Uses existing CT hardware and easily integrates into clinical workflows across the I-MED network.
•
CT LVAS™ will position 4DMedical to leverage I-MED's extensive existing CT network to provide greater patient access.
•
I-MED agreement to drive revenue for the Company, as it creates a framework for the rapid commercialisation of the CT LVASTM product
in Australia.
4DMedical Limited | Investor Presentation | November 2022
22View entire presentation